Addex Therapeutics
ADXN
#9803
Rank
โ‚ฌ8.74 M
Marketcap
7,64ย โ‚ฌ
Share price
-1.71%
Change (1 day)
36.04%
Change (1 year)

P/E ratio for Addex Therapeutics (ADXN)

P/E ratio as of November 2024 (TTM): -0.4212

According to Addex Therapeutics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.421232. At the end of 2023 the company had a P/E ratio of -0.3028.

P/E ratio history for Addex Therapeutics from 2020 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2023-0.302843.58%
2022-0.2109-90.13%
2021-2.14-51.21%
2020-4.38

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.